Literature DB >> 6827654

Control of adenovirus gene expression: cellular gene products restrict expression of adenovirus host range mutants in nonpermissive cells.

M G Katze, H Persson, B M Johansson, L Philipson.   

Abstract

Adenovirus type 5 (Ad5) host range mutants dl312 and hr-1, with lesions in region E1A (0 to 4.5 map units) of the viral genome, fail to accumulate virus-specific early RNA during infection in HeLa cells. In a recent report, we showed that the addition of anisomycin, a stringent inhibitor of protein synthesis, at 1 h after infection of HeLa cells with hr-1 virus resulted in the accumulation of properly spliced and translatable mRNA from all early regions (M. G. Katze, H. Persson, and L. Philipson, Mol. Cell. Biol. 1:807-813, 1981). Based on these results we proposed a model in which expression of early mutant RNA was achieved through inactivation of a cellular protein normally causing a reduction in the amount of viral RNA. These studies have been extended in the present report, which shows that early viral proteins can be detected in Ad5 dl312- and Ad5 hr-1-infected HeLa cells which have been treated for several hours with anisomycin either shortly after infection or before infection. A pulse of drug treatment also resulted in expression of substantial amounts of adenovirus structural proteins after infection with both Ad5 hr-1 and Ad5 dl312, whereas in drug-free controls no late proteins were detected. The Ad5 hr-1 virus previously reported to be DNA replication negative in nonpermissive HeLa cells was found to replicate its DNA, albeit at low levels, when anisomycin was present either from 1 to 5 h postinfection or for 5 h before infection. When infectious virus production was examined in mutant-infected cells the titer of Ad5 dl312 virus was found to increase at least 500-fold in anisomycin-treated HeLa cells. Taken together, these and our previous results suggest that the block in gene expression characteristic for complementation group I Ad5 host range mutants in HeLa cells can be overcome by inactivating cellular gene products serving as negative regulators of viral gene expression.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6827654      PMCID: PMC255092     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

4.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

5.  Host-range mutants of adenovirus type 5 defective for growth in HeLa cells.

Authors:  T Harrison; F Graham; J Williams
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

6.  Purification and characterization of the phosphorylated DNA-binding protein from adenovirus-type-2-infected cells.

Authors:  T Linné; H Jörnvall; L Philipson
Journal:  Eur J Biochem       Date:  1977-06-15

7.  Synthesis of a structural adenovirus polypeptide in the absence of viral DNA replication.

Authors:  H Persson; U Pettersson; M B Mathews
Journal:  Virology       Date:  1978-10-01       Impact factor: 3.616

8.  Synthesis of DNA, late polypeptides, and infectious virus by host-range mutants of adenovirus 5 in nonpermissive cells.

Authors:  N J Lassam; S T Bayley; F L Graham
Journal:  Virology       Date:  1978-06-15       Impact factor: 3.616

9.  Effect of protein synthesis inhibitors on viral mRNA's synthesized early in adenovirus type 2 infection.

Authors:  F Eggerding; H J Raskas
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

10.  Structure of the adenovirus 2 early mRNAs.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

View more
  9 in total

Review 1.  The structure and functions of the adenovirus early region 1 proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

2.  The interplay between host and viral genes in adenovirus gene expression.

Authors:  L Philipson
Journal:  Klin Wochenschr       Date:  1984-05-15

3.  Accelerated onset of viral transcription in adenovirus-infected HeLa cells treated with the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate.

Authors:  T H Carter; Z Z Milovanovic; L E Babiss; P B Fisher
Journal:  Mol Cell Biol       Date:  1984-03       Impact factor: 4.272

4.  Control functions of adenovirus transformation region E1A gene products in rat and human cells.

Authors:  A J Bellett; P Li; E T David; E J Mackey; A W Braithwaite; J R Cutt
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

5.  Differential activation of RNA polymerase III-transcribed genes by the polyomavirus enhancer and the adenovirus E1A gene products.

Authors:  S L Berger; W R Folk
Journal:  Nucleic Acids Res       Date:  1985-02-25       Impact factor: 16.971

6.  Expression of the E4 gene is required for establishment of soft-agar colony-forming rat cell lines transformed by the adenovirus 12 E1 gene.

Authors:  K Shiroki; S Hashimoto; I Saito; Y Fukui; Y Fukui; H Kato; H Shimojo
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

7.  The adenovirus-2 EIIa early gene promoter: sequences required for efficient in vitro and in vivo transcription.

Authors:  R Elkaim; C Goding; C Kédinger
Journal:  Nucleic Acids Res       Date:  1983-10-25       Impact factor: 16.971

8.  trans Activation of the simian virus 40 late transcription unit by T-antigen.

Authors:  J Brady; G Khoury
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

9.  A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model.

Authors:  Julius W Kim; Jason Miska; Jacob S Young; Aida Rashidi; J Robert Kane; Wojciech K Panek; Deepak Kanojia; Yu Han; Irina V Balyasnikova; Maciej S Lesniak
Journal:  Mol Ther Oncolytics       Date:  2017-05-06       Impact factor: 7.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.